- Report
- February 2025
- 136 Pages
Global
From €2862EUR$2,999USD£2,398GBP
- Report
- September 2024
- 175 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- November 2024
- 77 Pages
Global
From €3500EUR$3,929USD£3,035GBP
The Radioactive Stent market is a subset of the larger Stent market. Radioactive Stents are used to treat coronary artery disease, a condition in which the arteries become narrowed or blocked due to the buildup of plaque. Radioactive Stents are coated with a radioactive material, which helps to reduce the risk of restenosis, a condition in which the artery becomes blocked again after the stent is placed. Radioactive Stents are typically used in combination with other treatments, such as angioplasty or bypass surgery.
Radioactive Stents are used in a variety of medical settings, including hospitals, clinics, and private practices. They are typically used in patients who have had a previous stent procedure, or in those who have a high risk of restenosis.
Some companies in the Radioactive Stent market include Boston Scientific, Abbott Vascular, Medtronic, and Biotronik. Show Less Read more